Literature DB >> 24183781

Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.

Zuzana Krejciova1, Paul De Sousa2, Jean Manson3, James W Ironside1, Mark W Head4.   

Abstract

The molecular mechanisms involved in human cellular susceptibility to prion infection remain poorly defined. This is due, in part, to the absence of any well characterized and relevant cultured human cells susceptible to infection with human prions, such as those involved in Creutzfeldt-Jakob disease. In variant Creutzfeldt-Jakob disease, prion replication is thought to occur first in the lymphoreticular system and then spread into the brain. We have, therefore, examined the susceptibility of a human tonsil-derived follicular dendritic cell-like cell line (HK) to prion infection. HK cells were found to display a readily detectable, time-dependent increase in cell-associated abnormal prion protein (PrP(TSE)) when exposed to medium spiked with Creutzfeldt-Jakob disease brain homogenate, resulting in a coarse granular perinuclear PrP(TSE) staining pattern. Despite their high level of cellular prion protein expression, HK cells failed to support infection, as judged by longer term maintenance of PrP(TSE) accumulation. Colocalization studies revealed that exposure of HK cells to brain homogenate resulted in increased numbers of detectable lysosomes and that these structures immunostained intensely for PrP(TSE) after exposure to Creutzfeldt-Jakob disease brain homogenate. Our data suggest that human follicular dendritic-like cells and perhaps other human cell types are able to avoid prion infection by efficient lysosomal degradation of PrP(TSE).
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24183781      PMCID: PMC3873479          DOI: 10.1016/j.ajpath.2013.09.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein.

Authors:  D C Lee; C J Stenland; R C Hartwell; E K Ford; K Cai; J L Miller; K J Gilligan; R Rubenstein; M Fournel; S R Petteway
Journal:  J Virol Methods       Date:  2000-01       Impact factor: 2.014

2.  Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes.

Authors:  H S Kim; X Zhang; Y S Choi
Journal:  J Immunol       Date:  1994-10-01       Impact factor: 5.422

3.  4-hydroxytamoxifen leads to PrPSc clearance by conveying both PrPC and PrPSc to lysosomes independently of autophagy.

Authors:  Ludovica Marzo; Zrinka Marijanovic; Duncan Browman; Zeina Chamoun; Anna Caputo; Chiara Zurzolo
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

4.  Effects of new amphotericin analogues on the scrapie isoform of the prion protein.

Authors:  Lara Soler; Patrick Caffrey; Hilary E M McMahon
Journal:  Biochim Biophys Acta       Date:  2008-07-18

5.  PrP polymorphisms tightly control sheep prion replication in cultured cells.

Authors:  Elifsu Sabuncu; Stéphanie Petit; Annick Le Dur; Thanh Lan Lai; Jean-Luc Vilotte; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Standards for the assay of Creutzfeldt-Jakob disease specimens.

Authors:  P Minor; J Newham; N Jones; C Bergeron; L Gregori; D Asher; F van Engelenburg; T Stroebel; M Vey; G Barnard; M Head
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

7.  Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitro.

Authors:  Zuzana Krejciova; Steve Pells; Enrico Cancellotti; Paz Freile; Matthew Bishop; Kay Samuel; G Robin Barclay; James W Ironside; Jean C Manson; Marc L Turner; Paul De Sousa; Mark W Head
Journal:  J Pathol       Date:  2011-02-21       Impact factor: 7.996

8.  Identification of an intracellular site of prion conversion.

Authors:  Zrinka Marijanovic; Anna Caputo; Vincenza Campana; Chiara Zurzolo
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

9.  Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy.

Authors:  E M Manders; J Stap; G J Brakenhoff; R van Driel; J A Aten
Journal:  J Cell Sci       Date:  1992-11       Impact factor: 5.285

10.  Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeldt-Jakob patient.

Authors:  A Ladogana; Q Liu; Y G Xi; M Pocchiari
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

View more
  4 in total

Review 1.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

2.  Human stem cell-derived astrocytes replicate human prions in a PRNP genotype-dependent manner.

Authors:  Zuzana Krejciova; James Alibhai; Chen Zhao; Robert Krencik; Nina M Rzechorzek; Erik M Ullian; Jean Manson; James W Ironside; Mark W Head; Siddharthan Chandran
Journal:  J Exp Med       Date:  2017-11-15       Impact factor: 14.307

Review 3.  From Cell Culture to Organoids-Model Systems for Investigating Prion Strain Characteristics.

Authors:  Hailey Pineau; Valerie L Sim
Journal:  Biomolecules       Date:  2021-01-14

4.  Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.

Authors:  Young Pyo Choi; Mark W Head; James W Ironside; Suzette A Priola
Journal:  Am J Pathol       Date:  2014-09-30       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.